Active, Not Recruiting
UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade
NCT03474497
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +37 more
- Locations
-
- UC Davis Medical Center Sacramento, California, United States
- University of California Davis Medical Center Sacramento, California, United States